Pictet Asset Management (UK)’s Burning Rock Biotech BNR Stock Holding History

Pictet Asset Management (UK)’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.44M	Buy	+4,900	New	+$1.45M	﹤0.01%	1051

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Pictet Asset Management (UK)'s BNR Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Burning Rock Biotech (BNR) in Q2 2021: 4,900 shares worth $1.44M. The stake represents ﹤0.01% of the portfolio and ranks #1051 among its holdings.

85 funds tracked by Wall St. Rank hold BNR as of Q2 2021.

Pictet Asset Management (UK) held 4,900 shares of Burning Rock Biotech worth $1.44M as of Q2 2021.
Burning Rock Biotech was a new Pictet Asset Management (UK) position in Q2 2021.
Burning Rock Biotech made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1051 holding.
85 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.